This page summarizes publicly documented legal disputes, financial records, and business filings related to Mark Edward Bianchi and entities he has controlled or promoted, including Parkhill Capital Group, Parkhill Advisory Group, and Titan Capital Recovery Group. The information below is drawn from court filings, regulatory records, and a comprehensive third-party due diligence report prepared in October 2024.
No findings of liability are asserted here. The purpose of this page is to present facts that potential investors may wish to review before engaging in transactions or advisory relationships.
Court records across multiple jurisdictions show repeated lawsuits involving unpaid obligations, contract disputes, and family law enforcement actions.
Key findings include:
These matters remain visible in public dockets and have not been fully resolved as of the report date.
Mark Edward Bianchi is a California-born executive who currently identifies himself as CEO of Parkhill Capital Group. Over the past two decades, Bianchi has been associated with numerous entities in media, insurance, tax planning, and financial consulting.
Public biographies and promotional materials describe him as a tax planning and investment professional. However, court records and regulatory filings paint a more complicated picture that includes extensive litigation, unresolved judgments, dissolved entities, and significant tax liens.
One of the most striking findings for potential investors involves the contradiction between Bianchi’s marketing as a tax planning expert and his personal tax history.
Public records show:
For investors evaluating tax-driven strategies or charitable structures, unresolved or repeated tax enforcement actions against a promoter are commonly viewed as a material risk indicator.
Bianchi has operated under multiple business names, several of which show administrative dissolution, inactivity, or unclear legal standing.
Examples include:
Investors typically view inconsistent entity status, dissolved corporations, and unclear operating structures as red flags when evaluating counterparties.
The due-diligence report documents that client success stories promoted on Bianchi’s websites were copied nearly verbatim from a separate, publicly traded company in the life-settlement space.
The stories were presented in a way that could reasonably give prospective clients the impression they reflected Titan or Parkhill-specific outcomes. This practice raises concerns about misleading marketing representations, especially in regulated financial or tax-sensitive contexts.
According to the report and related litigation, Bianchi and associated entities promoted Head Genetics, a company that made ambitious claims about proprietary technology and investment opportunities with charitable components.
Solidaris Capital, after reviewing Head Genetics, reportedly declined to proceed due to red flags uncovered during due diligence. Head Genetics is now a defendant in civil litigation involving fraud allegations, contested valuations, and disputed representations.
The pattern is familiar to investors who lived through Theranos:
Theranos founder Elizabeth Holmes was once celebrated as a visionary and received major awards before the company collapsed under investigative scrutiny. History shows that early promotional enthusiasm can blind intermediaries and reporters to warning signs that later become obvious.
Taken together, the records raise questions that prudent investors typically ask before proceeding:
Investors evaluating Parkhill-related opportunities may wish to review these public records carefully and seek independent legal and financial advice.
This page is based on court filings, regulatory records, and the Mark Bianchi Due Diligence Report (October 2024) prepared by a third-party investigator. No conclusions of liability are asserted. All matters described are alleged, pending, or based on public records.
Copyright © 2025 Parkhill US and Mark Bianchi Facts - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.